Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Yunkang Group Limited ( (HK:2325) ).
Yunkang Group Limited reported a significant decline in its financial performance for the year ended December 31, 2024, with a 20.1% decrease in revenue compared to the previous year. The company experienced substantial losses, with a loss before income tax of RMB 791,191,000, marking an 811.4% increase from the prior year. This downturn is attributed to decreased revenue across all service categories, impacting the company’s profitability and market positioning.
More about Yunkang Group Limited
Yunkang Group Limited is a company incorporated in the Cayman Islands, focusing on diagnostic testing services. It provides diagnostic testing services for medical institution alliances, diagnostic outsourcing services, and diagnostic testing services for non-medical institutions.
YTD Price Performance: -67.53%
Average Trading Volume: 119,327
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.86B
Find detailed analytics on 2325 stock on TipRanks’ Stock Analysis page.